Inactive Instrument
Phosphagenics Limited Share Price Australian S.E.
Stocks
AU000000POH7
Pharmaceuticals
OTC Markets Traded| Market Cap | 84.27M 58.84M 51.42M 47.45M 43.74M 82.44M 5.67B 567M 223M 2.78B 221M 216M 9.55B | P/E 2024 |
-2.5x | P/E 2025 | -6.43x |
|---|---|---|---|---|---|
| Enterprise Value | 79.62M 55.6M 48.59M 44.83M 41.33M 77.89M 5.35B 536M 211M 2.62B 209M 204M 9.03B | EV / Sales 2024 |
5.85x | EV / Sales 2025 | 23x |
| Free-Float |
76.76% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -14.29% |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul David Gavin
CEO | Chief Executive Officer | - | 30/04/2020 |
Roksan Libinaki
COO | Chief Operating Officer | - | 30/04/2020 |
Naomi Lawrie
SEC | Corporate Secretary | - | 30/04/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Ross Murdoch
BRD | Director/Board Member | - | 12/04/2015 |
Gregory Collier
CHM | Chairman | - | 31/12/2018 |
Kathy Connell
BRD | Director/Board Member | 59 | 25/04/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -14.29% | -14.29% | - | - | 58.84M | ||
| +0.85% | -0.80% | +52.79% | +161.33% | 1,051B | ||
| +1.23% | -1.53% | +54.58% | +59.08% | 609B | ||
| +0.04% | +2.58% | +34.47% | +86.33% | 450B | ||
| +0.78% | -0.71% | +29.28% | +24.10% | 330B | ||
| +1.41% | +0.58% | +35.44% | +40.67% | 284B | ||
| -0.27% | -1.87% | +22.34% | +22.51% | 263B | ||
| -1.76% | +2.37% | -20.43% | -38.00% | 223B | ||
| -1.42% | +0.80% | +24.27% | +57.50% | 198B | ||
| -1.48% | +3.43% | +24.08% | +71.67% | 167B | ||
| Average | -1.49% | +0.54% | +28.54% | +53.91% | 397.23B | |
| Weighted average by Cap. | +0.37% | +0.02% | +37.51% | +79.63% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 1.13M 791K 691K 638K 588K 1.11M 76.17M 7.62M 3M 37.3M 2.97M 2.91M 128M | 1.24M 864K 755K 697K 642K 1.21M 83.23M 8.33M 3.28M 40.76M 3.25M 3.17M 140M |
| Net income | -3.12M -2.18M -1.91M -1.76M -1.62M -3.05M -210M -21.01M -8.26M -103M -8.19M -8.01M -354M | -4.42M -3.08M -2.7M -2.49M -2.29M -4.32M -297M -29.73M -11.69M -145M -11.58M -11.33M -501M |
| Net Debt | -1.3M -906K -792K -731K -674K -1.27M -87.27M -8.74M -3.44M -42.74M -3.4M -3.33M -147M | -4.65M -3.25M -2.84M -2.62M -2.41M -4.55M -313M -31.29M -12.31M -153M -12.19M -11.92M -527M |
Employees
-
Sector
Pharmaceuticals
















